EFFECTORS AND REGULATORS OF NORMAL AND ONCOGENIC RAS

正常和致癌 RAS 的效应器和调节器

基本信息

  • 批准号:
    2667940
  • 负责人:
  • 金额:
    $ 20.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1992
  • 资助国家:
    美国
  • 起止时间:
    1992-07-02 至 2002-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (adapted from the investigator's abstract) Ras proteins serve as critical control elements in the response of cells to external signals. The stimulation of some plasma membrane receptors can lead to activation of Ras and a mitogenic response. Mutant, constitutively active, forms of Ras can lead to a persistent mitotic signal that is independent of receptor stimulation. Such Ras mutations are among the most common causative events in human tumors. In some specialized mammalian cell types, however, Ras activation leads to cell cycle arrest and differentiation. This suggests that cell type differences provide a context for the interpretation of Ras signals which may lead to either cell cycle progression or arrest and differentiation. One downstream pathway directly connecting Ras activation to changes in gene expression that are required for cell division has been uncovered. The key first step is activation of the protein kinase Raf1. This is initiated by a physical interaction between Raf1 and Ras. There are however, other Ras-mediated events that appear to be required for a full transformation or differentiation response, suggesting the involvement of additional Ras interaction partners. They have isolated and are continuing to study Rin1, a human protein that binds specifically to activated Ras and can compete with Raf1. There are additional parallels between Rin 1 and Raf1 behavior, including their interactions with 14-3-3 proteins. Tissue type expression of Rin1 is regulated over a wide range. In addition, some splice variant forms of Rin1 have altered properties. Their findings are consistent with Rin1 functioning as a regulated Ras effector, as a Raf1 competitor or as both. Interestingly, the rin 1 gene has been mapped to 11q13.2, a chromosomal position that is frequently amplified in squamous cell carcinomas and breast tumors. This proposal includes an analysis of Rin1 binding properties and function. The focus is on interactions that occur in mammalian cells (co-immunoprecipitations and co-immunofluorescence) and on the biological consequences of those interactions (effects on Ras-mediated transformation and differentiation). They will take advantage of both artificial and naturally occurring variants of Rin1 that have different binding properties. These studies, directed at the role of Rin1 function in Ras-mediated signal transduction, should facilitate their understanding of normal cellular processes including differentiation and mitosis as well as cancer pathologies.
描述:(改编自研究者的摘要)Ras蛋白 作为细胞对外部信号反应的关键控制元件。 一些质膜受体的刺激可导致细胞膜的激活。 Ras和促有丝分裂反应。 Ras的组成型活性突变形式 可以导致不依赖于受体的持续的有丝分裂信号 刺激. 这种Ras突变是最常见的致病事件之一, in human人tumors肿瘤. 然而,在某些特殊的哺乳动物细胞类型中,Ras 活化导致细胞周期停滞和分化。 这表明 细胞类型的差异为Ras的解释提供了背景, 可能导致细胞周期进展或停滞的信号, 分化 一条下游通路直接将Ras激活与基因改变联系起来, 细胞分裂所需的表达已经被发现。 关键 第一步是激活蛋白激酶Raf 1。 这是由一个 Raf 1和Ras之间的物理相互作用。然而,其他 Ras介导的事件似乎是完全转化所必需的, 分化反应,表明参与额外的Ras 互动伙伴。 他们已经分离并继续研究Rin 1, 一种与激活的Ras特异性结合并可以竞争的人类蛋白质 关于Raf 1 Rin 1和Raf 1行为之间还有其他相似之处, 包括它们与14-3-3蛋白的相互作用。 Rin 1的组织类型表达在宽范围内调节。 此外,本发明还提供了一种方法, Rin 1的一些剪接变体形式具有改变的性质。 他们的发现 与Rin 1作为受调节的Ras效应子起作用一致,Rin 1作为Raf 1 竞争对手或两者。 有趣的是,rin 1基因已经被定位到 11q13.2,在鳞状细胞癌中经常扩增的染色体位置 细胞癌和乳腺肿瘤。 该建议包括Rin 1结合特性和功能的分析。 重点是发生在哺乳动物细胞中的相互作用 (共免疫沉淀和共免疫荧光)和生物学 这些相互作用的后果(对Ras介导的转化的影响 差异化)。 他们将利用人工和 Rin 1的天然变体具有不同的结合特性。 这些研究针对Rin 1功能在Ras介导的信号传导中的作用, 转导,应该有助于他们理解正常细胞 包括分化和有丝分裂以及癌症 病理学

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN J. COLICELLI其他文献

JOHN J. COLICELLI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN J. COLICELLI', 18)}}的其他基金

A Novel Screen for Compounds that Outflank BCR-ABL Drug-Resistance
突破 BCR-ABL 耐药性的化合物的新筛选
  • 批准号:
    8067981
  • 财政年份:
    2009
  • 资助金额:
    $ 20.49万
  • 项目类别:
A Novel Screen for Compounds that Outflank BCR-ABL Drug-Resistance
突破 BCR-ABL 耐药性的化合物的新筛选
  • 批准号:
    7725809
  • 财政年份:
    2009
  • 资助金额:
    $ 20.49万
  • 项目类别:
Mechanism of RIN1 Signaling in Neuronal Plasticity
RIN1 信号传导在神经元可塑性中的机制
  • 批准号:
    6773149
  • 财政年份:
    2003
  • 资助金额:
    $ 20.49万
  • 项目类别:
Mechanism of RIN1 Signaling in Neuronal Plasticity
RIN1 信号传导在神经元可塑性中的机制
  • 批准号:
    7259412
  • 财政年份:
    2003
  • 资助金额:
    $ 20.49万
  • 项目类别:
Mechanism of RIN1 Signaling in Neuronal Plasticity
RIN1 信号传导在神经元可塑性中的机制
  • 批准号:
    6681142
  • 财政年份:
    2003
  • 资助金额:
    $ 20.49万
  • 项目类别:
Mechanism of RIN1 Signaling in Neuronal Plasticity
RIN1 信号传导在神经元可塑性中的机制
  • 批准号:
    7067644
  • 财政年份:
    2003
  • 资助金额:
    $ 20.49万
  • 项目类别:
Mechanism of RIN1 Signaling in Neuronal Plasticity
RIN1 信号传导在神经元可塑性中的机制
  • 批准号:
    6910730
  • 财政年份:
    2003
  • 资助金额:
    $ 20.49万
  • 项目类别:
MECHANISM OF ENZYME INHIBITION BY PHARMACOLOGICAL AGENTS
药理制剂抑制酶的机制
  • 批准号:
    2714522
  • 财政年份:
    1993
  • 资助金额:
    $ 20.49万
  • 项目类别:
MECHANISM OF ENZYME INHIBITION BY PHARMACOLOGICAL AGENTS
药理制剂抑制酶的机制
  • 批准号:
    2037678
  • 财政年份:
    1993
  • 资助金额:
    $ 20.49万
  • 项目类别:
MECHANISM OF ENZYME INHIBITION BY PHARMACOLOGICAL AGENTS
药理制剂抑制酶的机制
  • 批准号:
    3418801
  • 财政年份:
    1993
  • 资助金额:
    $ 20.49万
  • 项目类别:

相似海外基金

The expression of G protein-coupled receptor 3 modulates presynaptic function in differentiated PC12 cells
G蛋白偶联受体3的表达调节分化PC12细胞的突触前功能
  • 批准号:
    18K07392
  • 财政年份:
    2018
  • 资助金额:
    $ 20.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the lipidomic response to hypoxic shock in PC12 cells using mass spectrometry
使用质谱法研究 PC12 细胞对缺氧休克的脂质组学反应
  • 批准号:
    450981-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 20.49万
  • 项目类别:
    University Undergraduate Student Research Awards
A quantitative MS-based lipidomic analysis of PC12 cells during hypoxia
基于 MS 的缺氧期间 PC12 细胞的定量脂质组学分析
  • 批准号:
    417747-2011
  • 财政年份:
    2011
  • 资助金额:
    $ 20.49万
  • 项目类别:
    University Undergraduate Student Research Awards
Roles of sec6 and sec8 in the regulation of dense-core vesicle secretion in pc12 cells
sec6和sec8在pc12细胞致密核心囊泡分泌调节中的作用
  • 批准号:
    394661-2010
  • 财政年份:
    2010
  • 资助金额:
    $ 20.49万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
HUNTINGTON PROTEIN AGGREGATION IN PC12 CELLS
PC12 细胞中的亨廷顿蛋白聚集
  • 批准号:
    7724048
  • 财政年份:
    2008
  • 资助金额:
    $ 20.49万
  • 项目类别:
CAVEOLAE IN PC12 CELLS DIFFERENTIATION
PC12 细胞分化中的小窝
  • 批准号:
    6973832
  • 财政年份:
    2004
  • 资助金额:
    $ 20.49万
  • 项目类别:
GROWTH FACTOR REGULATION OF THE PN1 SODIUM CHANNEL IN PC12 CELLS
PC12 细胞中 PN1 钠通道生长因子的调节
  • 批准号:
    6338952
  • 财政年份:
    2000
  • 资助金额:
    $ 20.49万
  • 项目类别:
CYCLOOXYGENASE AND PC12 CELLS
环加氧酶和 PC12 细胞
  • 批准号:
    6325797
  • 财政年份:
    2000
  • 资助金额:
    $ 20.49万
  • 项目类别:
BIOCHEMICAL PROTEIN CHARACTERIZATION IN NGF SIGNAL TRANSDUCTION IN PC12 CELLS
PC12 细胞中 NGF 信号转导的生化蛋白质特征
  • 批准号:
    6308850
  • 财政年份:
    2000
  • 资助金额:
    $ 20.49万
  • 项目类别:
Structures and biological activities of indocarbazostain, new inhibitors of NGF-induced neurite outgrowth in PC12 cells.
吲哚卡唑斯坦的结构和生物活性,NGF 诱导的 PC12 细胞神经突生长的新抑制剂。
  • 批准号:
    11660114
  • 财政年份:
    1999
  • 资助金额:
    $ 20.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了